ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Faculty Opinions recommendation of Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.717952635.793458150
◽
2012
◽
Author(s):
Alex Thompson
Keyword(s):
Chronic Hepatitis
◽
Hepatitis C
◽
Chronic Hepatitis C
◽
Dose Finding
◽
Genotype 1
◽
Double Blind
◽
Double Blind Placebo
◽
Parallel Group
Download Full-text
Related Documents
Cited By
References
Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial
The Lancet Infectious Diseases
◽
10.1016/s1473-3099(12)70138-x
◽
2012
◽
Vol 12
(9)
◽
pp. 671-677
◽
Cited By ~ 110
Author(s):
Stanislas Pol
◽
Reem H Ghalib
◽
Vinod K Rustgi
◽
Claudia Martorell
◽
Greg T Everson
◽
...
Keyword(s):
Chronic Hepatitis
◽
Hepatitis C
◽
Chronic Hepatitis C
◽
Dose Finding
◽
Genotype 1
◽
Double Blind
◽
Double Blind Placebo
◽
Parallel Group
Download Full-text
Therapeutic vaccination in patients with chronic hepatitis C genotype 1 using four courses of 8 + 6 + 6 + 6 intramuscular injections of 50 µg E1y at 3 week intervals: a multicenter, 3:1 randomized, double-blind, placebo-controlled, parallel-group study over 157 weeks in 122 patients
http://isrctn.org/>
◽
10.1186/isrctn71794661
◽
2013
◽
Author(s):
Yves Horsmans
Keyword(s):
Chronic Hepatitis
◽
Hepatitis C
◽
Chronic Hepatitis C
◽
Therapeutic Vaccination
◽
Genotype 1
◽
Double Blind
◽
Double Blind Placebo
◽
Parallel Group Study
◽
Intramuscular Injections
◽
Parallel Group
Download Full-text
1188 PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF NITAZOXANIDE WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN NONRESPONDERS (NR) WITH CHRONIC HEPATITIS C GENOTYPE 1: FINAL REPORT
Journal of Hepatology
◽
10.1016/s0168-8278(10)61189-0
◽
2010
◽
Vol 52
◽
pp. S461
◽
Cited By ~ 3
Author(s):
M.L. Shiffman
◽
A. Ahmed
◽
I.M. Jacobson
◽
R.E. Pruitt
◽
E.B. Keeffe
Keyword(s):
Chronic Hepatitis
◽
Hepatitis C
◽
Chronic Hepatitis C
◽
Controlled Study
◽
Final Report
◽
Phase 2
◽
Genotype 1
◽
Double Blind
◽
Double Blind Placebo
◽
Peginterferon Alfa
Download Full-text
Randomized, double-blind, placebo-controlled study of peginterferon alfa-2a (40KD) plus ribavirin with or without amantadine in treatment-naïve patients with chronic hepatitis C genotype 1 infection
Journal of Hepatology
◽
10.1016/j.jhep.2005.09.015
◽
2006
◽
Vol 44
(2)
◽
pp. 275-282
◽
Cited By ~ 47
Author(s):
Peter Ferenci
◽
Elisabeth Formann
◽
Hermann Laferl
◽
Michael Gschwantler
◽
Franz Hackl
◽
...
Keyword(s):
Chronic Hepatitis
◽
Hepatitis C
◽
Chronic Hepatitis C
◽
Controlled Study
◽
Genotype 1
◽
Double Blind
◽
Double Blind Placebo
◽
Treatment Naïve
◽
Peginterferon Alfa
Download Full-text
Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial
Yearbook of Gastroenterology
◽
10.1016/j.ygas.2011.07.125
◽
2011
◽
Vol 2011
◽
pp. 243-245
Author(s):
D.M. Harnois
Keyword(s):
Chronic Hepatitis
◽
Hepatitis C
◽
Combination Therapy
◽
Chronic Hepatitis C
◽
Dose Escalation
◽
Genotype 1
◽
Double Blind
◽
Double Blind Placebo
◽
Polymerase Inhibitor
Download Full-text
Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial
The Lancet
◽
10.1016/s0140-6736(10)61384-0
◽
2010
◽
Vol 376
(9751)
◽
pp. 1467-1475
◽
Cited By ~ 250
Author(s):
Edward J Gane
◽
Stuart K Roberts
◽
Catherine AM Stedman
◽
Peter W Angus
◽
Brett Ritchie
◽
...
Keyword(s):
Chronic Hepatitis
◽
Hepatitis C
◽
Combination Therapy
◽
Chronic Hepatitis C
◽
Dose Escalation
◽
Genotype 1
◽
Double Blind
◽
Double Blind Placebo
◽
Polymerase Inhibitor
Download Full-text
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Nitazoxanide Plus Peginterferon and Ribavirin in Naïve Patients With Chronic Hepatitis C Genotype 1 Infection: Final Report
Gastroenterology
◽
10.1053/j.gastro.2010.05.067
◽
2010
◽
Vol 139
(1)
◽
pp. e18
◽
Cited By ~ 4
Author(s):
Bruce R. Bacon
◽
Mitchell L. Shiffman
◽
Joseph K. Lim
◽
Arthur Berman
◽
Vinod K. Rustgi
◽
...
Keyword(s):
Chronic Hepatitis
◽
Hepatitis C
◽
Chronic Hepatitis C
◽
Phase Ii
◽
Controlled Study
◽
Final Report
◽
Genotype 1
◽
Double Blind
◽
Double Blind Placebo
◽
Peginterferon And Ribavirin
Download Full-text
A randomized double blind, placebo controlled trial of a Chinese herbal preparation (CH100) in chronic Hepatitis C
Gastroenterology
◽
10.1016/s0016-5085(01)81907-7
◽
2001
◽
Vol 120
(5)
◽
pp. A384-A384
Author(s):
L MOLLISON
◽
L TOTTEN
◽
C HOVELL
◽
K THAYNE
◽
C CONNELLY
◽
...
Keyword(s):
Chronic Hepatitis
◽
Hepatitis C
◽
Chronic Hepatitis C
◽
Controlled Trial
◽
Herbal Preparation
◽
Double Blind
◽
Double Blind Placebo
◽
Chinese Herbal
Download Full-text
324 EFFECT OF VITAMIN D SUPPLEMENT ON T HELPER1/2 CYTOKINE LEVELS IN CHRONIC HEPATITIS C PATIENTS; A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PILOT STUDY
Journal of Hepatology
◽
10.1016/s0168-8278(13)60326-8
◽
2013
◽
Vol 58
◽
pp. S135
Author(s):
K. Charoensuk
◽
C. Chirathaworn
◽
K. Thanapirom
◽
S. Suksawatamnuay
◽
P. Thaimai
◽
...
Keyword(s):
Vitamin D
◽
Chronic Hepatitis
◽
Hepatitis C
◽
Pilot Study
◽
Chronic Hepatitis C
◽
Double Blind
◽
Double Blind Placebo
◽
Cytokine Levels
◽
Chronic Hepatitis C Patients
◽
Vitamin D Supplement
Download Full-text
A randomised, double blind, placebo controlled trial of interferon alpha2b with and without ribavirin in mild chronic hepatitis C infection
Journal of Hepatology
◽
10.1016/s0168-8278(01)81376-3
◽
2001
◽
Vol 34
◽
pp. 138
Author(s):
H. Verbaan
◽
S. Lindgren
◽
A. Widell
Keyword(s):
Chronic Hepatitis
◽
Hepatitis C
◽
Chronic Hepatitis C
◽
Controlled Trial
◽
Hepatitis C Infection
◽
Double Blind
◽
Double Blind Placebo
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close